Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.

Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

OKAY, HONEY, COME SIT HERE. TODAY, JOE IS TESTING SOMETHING NEW. A MEDICATION CALLED FOR INSIDE THIS NASAL SPRAY. ONE, TWO. THREE. JOE IS THE FIRST PATIENT WITH ALZHEIMER’S TO TRY THIS DRUG.

Less than two months since free naloxone kiosks debuted around the region, community members have taken more than 1,200 boxes ...

Just a few puffs into each nostril, and you're protected against infection from nasty cold viruses - that is, according to claims made for many nasal sprays. Can they really do this?Well, not directly ...

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...